This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Boyd, C. Articles by Mackillop, W. J. Search for Related Content PubMed PubMed Citation Articles by Boyd, C. Articles by Mackillop, W. J.

Associations Between Community Income and Cancer Survival in Ontario, Canada, and the United States

From the The Radiation Oncology Research Unit and Departments of Oncology and Community Health and Epidemiology, Queen's University, Kingston Regional Cancer Centre, Kingston; and Kingston General Hospital, Kingston, Ontario, Canada.

Address reprint requests to William J. Mackillop, MD, Radiation Oncology Research Unit, Kingston General Hospital, Apps Level 4, Kingston, Ontario K7L 2V7 Canada; email william.mackillop{at}cancercare.on.ca

PURPOSE: The objectives of this study were as follows: (1) to compare the magnitude of the association between socioeconomic status (SES) and cancer survival in the Canadian province of Ontario with that in the United States (U.S.), and (2) to compare cancer survival in communities with similar SES in Ontario and in the U.S.

METHODS: The Ontario Cancer Registry provided information about all cases of invasive cancer diagnosed in Ontario from 1987 to 1992, and the Surveillance, Epidemiology and End Results Registry (SEER) provided information about all cases diagnosed in the SEER regions of the U.S. during the same time period. Census data provided information about SES at the community level. The product-limit method was used to describe cause-specific survival. Cox proportional hazards models were used to describe the association between SES and the risk of death from cancer.

RESULTS: There were significant associations between SES and survival for most cancer sites in both the U.S. and Ontario, but the magnitude of the association was usually larger in the U.S. In the poorest communities, there were significant survival advantages in favor of cancer patients in Ontario for many disease groups, including cancers of the lung, head and neck region, cervix, and uterus. However, in upper- and middle-income communities, there were significant survival advantages in favor of the U.S. for all cases combined and for several individual diseases, including cancers of the breast, colon and rectum, prostate, and bladder.

CONCLUSION: The association between SES and cancer survival is weaker in Ontario than it is in the U.S. This is due to a combination of better survival among patients in the poorest communities and worse survival among patients in the wealthier communities of Ontario relative to those in the U.S.

This article has been cited by other articles:

				L. R. Shugarman, M. E.S. Sorbero, H. Tian, A. K. Jain, and J. S. Ashwood An Exploration of Urban and Rural Differences in Lung Cancer Survival Among Medicare Beneficiaries Am J Public Health, July 1, 2008; 98(7): 1280 - 1287. [Abstract] [Full Text] [PDF]

				L. M. Woods, B. Rachet, and M. P. Coleman Origins of socio-economic inequalities in cancer survival: a review Ann. Onc., January 1, 2006; 17(1): 5 - 19. [Abstract] [Full Text] [PDF]

				L. C. Harlan, A. L. Greene, L. X. Clegg, M. Mooney, J. L. Stevens, and M. L. Brown Insurance Status and the Use of Guideline Therapy in the Treatment of Selected Cancers J. Clin. Oncol., December 20, 2005; 23(36): 9079 - 9088. [Abstract] [Full Text] [PDF]

				S. M. Singh, L. F. Paszat, C. Li, J. He, C. Vinden, and L. Rabeneck Association of socioeconomic status and receipt of colorectal cancer investigations: a population-based retrospective cohort study Can. Med. Assoc. J., August 31, 2004; 171(5): 461 - 465. [Abstract] [Full Text] [PDF]

				E. B. Lamont, D. Hayreh, K. E. Pickett, J. J. Dignam, M. A. List, K. M. Stenson, D. J. Haraf, B. E. Brockstein, S. A. Sellergren, and E. E. Vokes Is Patient Travel Distance Associated With Survival on Phase II Clinical Trials in Oncology? J Natl Cancer Inst, September 17, 2003; 95(18): 1370 - 1375. [Abstract] [Full Text] [PDF]

				T. J. Iwashyna and E. B. Lamont Effectiveness of Adjuvant Fluorouracil in Clinical Practice: A Population-Based Cohort Study of Elderly Patients With Stage III Colon Cancer J. Clin. Oncol., October 1, 2002; 20(19): 3992 - 3998. [Abstract] [Full Text] [PDF]

				W. B. Sateren, E. L. Trimble, J. Abrams, O. Brawley, N. Breen, L. Ford, M. McCabe, R. Kaplan, M. Smith, R. Ungerleider, et al. How Sociodemographics, Presence of Oncology Specialists, and Hospital Cancer Programs Affect Accrual to Cancer Treatment Trials J. Clin. Oncol., April 15, 2002; 20(8): 2109 - 2117. [Abstract] [Full Text] [PDF]

				C. J. Bradley, C. W. Given, and C. Roberts Race, Socioeconomic Status, and Breast Cancer Treatment and Survival J Natl Cancer Inst, April 3, 2002; 94(7): 490 - 496. [Abstract] [Full Text] [PDF]

				D. C. Hodgson, C. S. Fuchs, and J. Z. Ayanian Impact of Patient and Provider Characteristics on the Treatment and Outcomes of Colorectal Cancer J Natl Cancer Inst, April 4, 2001; 93(7): 501 - 515. [Abstract] [Full Text] [PDF]